Trials / Recruiting

RecruitingNCT03967834

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group

Status: Recruiting
Phase: N/A
Study type: Interventional
Enrollment: 400 (estimated)

Sponsor: Institut Claudius Regaud · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

This trial is a translational, open-label, multi-sites, prospective and retrospective cohort study of 500 patients aimed at clinical and biological characterization of sarcoma of rare subtype. 400 patients will be included in this prospective cohort study; they will be identified in the investigating centers in the context of either routine care or a clinical study protocol. Retrospective cases of patients (100 cases in total) will be identified in all centers through the GSF/GETO clinical databases already setted up (including the clinical base Conticabase).

Conditions

Interventions

Type	Name	Description
OTHER	Patient with Soft Tissue Sarcoma	* Tumor specimens will be collected for the study at diagnosis. * A blood sample will be collected in all included patients at baseline, after the completion of the treatment (for patients included with a localized disease) or at the time of the first tumoral evaluation (for patients included with a metastatic disease), and at the time of progression. * Patient's data (clinical, biological and disease data) will also be collected at baseline visit and then at each time point planned in the center for clinical benefit assessment (i.e. every 2 or 3 months) until progression or for a maximum duration of 5 years.

Timeline

Start date: 2021-04-26
Primary completion: 2031-04-01
Completion: 2031-04-01
First posted: 2019-05-30
Last updated: 2026-02-10

Locations

20 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03967834. Inclusion in this directory is not an endorsement.